STOCK TITAN

Marex Group Ltd SEC Filings

MRX NASDAQ

Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marex Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marex Group's regulatory disclosures and financial reporting.

Rhea-AI Summary

Marex Group plc director John W. Pietrowicz has filed an initial ownership report showing 22,259 Ordinary Shares. This figure represents his direct holdings as reported in the Form 3. The amount includes 2,787 shares tied to restricted share awards, which are contingent rights that convert into ordinary shares only upon vesting and settlement of the awards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc filed an initial insider report for Nilesh Jethwa, CEO of Marex Solutions, showing his current equity position. The filing lists beneficial ownership of 287,015 Ordinary Shares.

This total includes 195,565 shares tied to deferred bonus plan awards previously granted to him. Each of these awards represents a contingent right to receive one ordinary share upon vesting and settlement, so part of his reported holding depends on future vesting conditions being met.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc director Linda Kristine Myers has filed an initial statement of beneficial ownership, reporting 22,259 ordinary shares held directly. This total includes 2,787 shares underlying restricted share awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marex Group plc director and Chief Financial Officer Irvin Rob filed an initial ownership report showing beneficial ownership of 38,104 ordinary shares. This total includes 32,443 shares tied to deferred bonus plan awards, which are contingent rights that only convert into ordinary shares when the awards vest and settle.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc director Ing Sarah has filed an initial Form 3 showing her ownership of the company’s ordinary shares. She reports 10,135 ordinary shares held directly, which include 2,787 shares underlying previously granted restricted share awards that may settle into ordinary shares upon vesting. She also reports 535 ordinary shares held indirectly through her spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc President Simon Van Den Born filed an initial ownership report showing direct holdings of 1,535,493 ordinary shares. This figure includes 383,741 shares underlying deferred bonus plan awards, which represent contingent rights to receive one ordinary share each upon vesting and settlement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marex Group plc officer Paolo Tonucci has filed an initial ownership report showing a direct holding of 1,380,023 ordinary shares. This total includes 286,871 shares underlying deferred bonus plan awards, each representing a right to receive one ordinary share upon vesting and settlement of the respective award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc Chief Executive Officer Ian T. Lowitt filed an initial ownership report showing he holds 2,907,979 ordinary shares. This total includes 278,406 shares underlying deferred bonus plan awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marex Group plc is offering Autocallable Contingent Income Barrier Notes linked to the worst performing of the EFA, RTY and NDX. The Notes are sold in $1,000 Principal Amount increments with an Estimated Initial Value of $950.00–$990.00 per Note and a Trade and Pricing Date of March 31, 2026.

The Notes pay a quarterly Contingent Coupon of at least 2.925% (equivalent to at least 11.70% per annum) if each Underlying is ≥70.00% of its Initial Value on a Coupon Determination Date, are callable if each Underlying is ≥100.00% on a Call Observation Date, and mature on April 5, 2028. At maturity, if the Worst Performing Underlying’s Reference Return is -30.00% or worse, investors bear 1:1 downside and may lose up to 100% of principal. All payments are subject to the credit risk of Marex.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Marex Group plc is offering Autocallable Leveraged Barrier Notes linked to the worst performing of the iShares® Silver Trust (SLV) and the VanEck® Gold Miners ETF (GDX). The notes have a $1,000 principal amount, Trade and Pricing Date of March 31, 2026, Original Issue Date April 6, 2026 and scheduled Maturity Date April 5, 2029.

If both Underlyings meet their Call Threshold on the Call Observation Date (April 7, 2027), notes are automatically called for principal plus a Call Premium of at least 26.50%. If not called, maturity payoffs use the Worst Performing Underlying: 3.00x upside participation for positive returns, principal return if the Reference Return is between 0% and the Barrier Percentage (-30%), and 1-to-1 downside exposure below the Barrier. The Estimated Initial Value is expected between $930.00 and $980.00. All payments are subject to Marex credit risk and the Notes pay no interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Marex Group (MRX) SEC filings are available on StockTitan?

StockTitan tracks 201 SEC filings for Marex Group (MRX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Marex Group (MRX)?

The most recent SEC filing for Marex Group (MRX) was filed on March 18, 2026.